Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading?

BACKGROUND: Some patients administered cholesterol-lowering therapies may experience an increase in the proportion of small LDL particles, which may be misinterpreted as a worsening of atherosclerotic coronary heart disease risk. This study assessed the lipid effects of adding ezetimibe to atorvasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold, Conard, Scott, Leiter, Lawrence A, Bird, Steven, Jensen, Erin, Hanson, Mary E, Shah, Arvind, Tershakovec, Andrew M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012666/
https://www.ncbi.nlm.nih.gov/pubmed/21118495
http://dx.doi.org/10.1186/1476-511X-9-136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012666/
https://www.ncbi.nlm.nih.gov/pubmed/21118495
http://dx.doi.org/10.1186/1476-511X-9-136

Ejemplares similares